{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:45:53Z","timestamp":1782380753459,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":141,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.nefro.2015.05.022","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T19:23:02Z","timestamp":1437592982000},"page":"207-217","source":"Crossref","is-referenced-by-count":13,"title":["Uso del sevelamer en la enfermedad renal cr\u00f3nica. M\u00e1s all\u00e1 del control del f\u00f3sforo"],"prefix":"10.1016","volume":"35","author":[{"given":"Laura","family":"Rodr\u00edguez-Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Pazmi\u00f1o","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Gracia-Iguacel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Gonz\u00e1lez","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supp 6","key":"10.1016\/j.nefro.2015.05.022_bib0005","first-page":"14","article-title":"Ri\u00f1\u00f3n y enfermedad cardiovascular","volume":"24","author":"Mar\u00edn","year":"2004","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2015.05.022_bib0010","unstructured":"Gu\u00edas de la Sociedad Espa\u00f1ola de nefrolog\u00eda sobre ri\u00f1\u00f3n y enfermedad cardiovascular. Nefrolog\u00eda. 2004; 24(Supp 6):1-187."},{"key":"10.1016\/j.nefro.2015.05.022_bib0015","first-page":"1831","article-title":"Board of the EURECA-m Working Group of ERA-EDTA","volume":"383","author":"Ortiz","year":"2014","journal-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure Lancet"},{"issue":"Suppl(1)","key":"10.1016\/j.nefro.2015.05.022_bib0020","first-page":"3","article-title":"Recomendaciones de la Sociedad espa\u00f1ola de Nefrolog\u00eda para el manejo de las alteraciones del metabolismo \u00f3seo y mineral en los pacientes con enfermedad renal cr\u00f3nica","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2015.05.022_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.carpath.2012.02.008","article-title":"Phosphate: a stealthier killer than previously thought?","volume":"21","author":"Gonzalez-Parra","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0030","doi-asserted-by":"crossref","first-page":"597605","DOI":"10.1155\/2012\/597605","article-title":"Phosphorus and nutrition in chronic kidney disease","volume":"2012","author":"Gonz\u00e1lez-Parra","year":"2012","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0035","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2015.05.022_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40265-014-0215-7","article-title":"Sevelamer carbonate: a review in hyperphosphataemia in adults with chronic kidney disease","volume":"74","author":"Perry","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.nefro.2015.05.022_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1345\/aph.1M291","article-title":"Sevelamer carbonate","volume":"44","author":"Barna","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nefro.2015.05.022_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jarr.2003.50016","article-title":"Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients","volume":"10","author":"Burke","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.nefro.2015.05.022_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000302723","article-title":"Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia","volume":"29","author":"Stinghen","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.nefro.2015.05.022_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.jrn.2011.10.031","article-title":"Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder","volume":"22","author":"Tanaka","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nefro.2015.05.022_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000343397","article-title":"Emerging effects of sevelamer in chronic kidney disease","volume":"37","author":"Ikee","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.nefro.2015.05.022_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.ki.5002178","article-title":"Association of serum fetuin-A levels with mortality in dialysis patients","volume":"72","author":"Hermans","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0080","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1753944713513061","article-title":"Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease","volume":"7","author":"Rastogi","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.nefro.2015.05.022_bib0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nephro.2014.04.001","article-title":"Pleiotropic effects of sevelamer: A model of intestinal tract chelating agent","volume":"10","author":"Massy","year":"2014","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nefro.2015.05.022_bib0090","first-page":"494","article-title":"Identification of a novel fibroblast growth factor","volume":"277","author":"Yamashita","year":"2000","journal-title":"FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain Biochem Biophys Res Commun"},{"key":"10.1016\/j.nefro.2015.05.022_bib0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nefro.2015.05.022_bib0100","doi-asserted-by":"crossref","unstructured":"ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345-8.","DOI":"10.1038\/81664"},{"key":"10.1016\/j.nefro.2015.05.022_bib0105","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nefro.2015.05.022_bib0110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2015.05.022_bib0115","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0120","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2015.05.022_bib0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2011.08.850","article-title":"Expression of FGF23\/KLOTHO system in human vascular tissue","volume":"165","author":"Donate-Correa","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nefro.2015.05.022_bib0135","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefro.2015.05.022_bib0140","first-page":"336","article-title":"; ROD21 Clinical Research Group","volume":"9","author":"Koiwa","year":"2005","journal-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients Ther Apher Dial"},{"key":"10.1016\/j.nefro.2015.05.022_bib0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0150","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/ndt\/gfq598","article-title":"The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol","volume":"26","author":"Pierce","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/nep.12319","article-title":"Long-term sevelamer treatment lowers serum fgf23 accompanied with increasing serum klotho levels in chronic hemodialysis patients","volume":"19","author":"Lin","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nefro.2015.05.022_bib0165","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/ndt\/gft234","article-title":"Disturbances of Wnt\/b-catenin pathway and energy metabolism in early CKD: effect of phosphate binders","volume":"28","author":"de Oliveira","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0170","doi-asserted-by":"crossref","first-page":"954956","DOI":"10.1155\/2013\/954956","article-title":"Endotoxin binding by sevelamer: potential impact on nutritional status","volume":"2013","author":"Kubotera","year":"2013","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.jrn.2011.05.004","article-title":"Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients","volume":"22","author":"Feroze","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.nefro.2015.05.022_bib0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000319850","article-title":"Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia","volume":"30","author":"Hauser","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.nefro.2015.05.022_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000323972","article-title":"Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation","volume":"33","author":"Noori","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0190","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin Dial"},{"key":"10.1016\/j.nefro.2015.05.022_bib0195","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/j.ajkd.2009.06.022","article-title":"Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients","volume":"54","author":"Raj","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2015.05.022_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ajcn\/80.2.299","article-title":"Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients","volume":"80","author":"Kalantar-Zadeh","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nefro.2015.05.022_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri1004","article-title":"Innate immune sensing and its roots: the story of endotoxin","volume":"3","author":"Beutler","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/msy.2002.126508","article-title":"25% Albumin modulates adhesive interactions between neutrophils and the endothelium following shock\/resuscitation","volume":"132","author":"Powers","year":"2002","journal-title":"Surgery"},{"issue":"1 Suppl","key":"10.1016\/j.nefro.2015.05.022_bib0215","doi-asserted-by":"crossref","first-page":"73A","DOI":"10.1111\/j.1530-0277.1996.tb01735.x","article-title":"Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading","volume":"20","author":"Kitano","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.nefro.2015.05.022_bib0220","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3748\/wjg.v9.i11.2385","article-title":"Gut in diseases: physiological elements and their clinical significance","volume":"9","author":"Ding","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0225","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/eurheartj\/ehi389","article-title":"The importance of the gastrointestinal system in the pathogenesis of heart failure","volume":"26","author":"Krack","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nefro.2015.05.022_bib0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04610510","article-title":"Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.femsim.2004.11.010","article-title":"Iron and infection: the heart of the matter","volume":"43","author":"Bullen","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/5.2.130","article-title":"Iron overload in haemodialysis patients increases the risk of bacteraemia: a prospective study","volume":"5","author":"Boelaert","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0245","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1159\/000135691","article-title":"Endotoxin-binding affinity of sevelamer hydrochloride","volume":"28","author":"Perianayagam","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0250","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2215\/CJN.12891211","article-title":"Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease","volume":"7","author":"Vlassara","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0255","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s10157-012-0640-4","article-title":"Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study","volume":"16","author":"Iimori","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/089686080702700618","article-title":"Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study","volume":"27","author":"Ramos","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0265","first-page":"142","article-title":"el al","volume":"24","author":"Su\u00f1er","year":"2004","journal-title":"Treatment of hyperphosphatemia with sevelamer in patients with chronic renal failure Nefrologia"},{"key":"10.1016\/j.nefro.2015.05.022_bib0270","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2012070719","article-title":"Cardiovascular effects of sevelamer in stage 3 CKD","volume":"24","author":"Chue","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0275","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfq818","article-title":"The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression","volume":"26","author":"Meijers","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 114","key":"10.1016\/j.nefro.2015.05.022_bib0280","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/ki.2009.402","article-title":"Uremic toxins originating from colonic microbial metabolism","volume":"76","author":"Evenepoel","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0285","first-page":"206","article-title":"Sevelamer hydrochloride adsorbs the uremic compound indoxyl sulfate [abstract]","volume":"14","author":"De Smet","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0290","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremiaenhanced atherosclerosis progression in apolipoprotein E-deficient mice","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2015.05.022_bib0295","doi-asserted-by":"crossref","first-page":"e73558","DOI":"10.1371\/journal.pone.0073558","article-title":"Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: Evidence from a cross-sectional observational study","volume":"8","author":"Guida","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nefro.2015.05.022_bib0300","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2215\/CJN.01270406","article-title":"Advanced glycation end products and nephrotoxicity of high-protein diets","volume":"1","author":"Uribarri","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0305","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2009-0089","article-title":"Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1","volume":"94","author":"Vlassara","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nefro.2015.05.022_bib0310","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/gerona\/gls195","article-title":"Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift","volume":"67","author":"Vlassara","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nefro.2015.05.022_bib0315","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients","volume":"57","author":"Kakuta","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2015.05.022_bib0320","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5414\/CN107352","article-title":"Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease","volume":"77","author":"Yelken","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0325","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2169\/internalmedicine.48.1817","article-title":"Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients","volume":"48","author":"Ohno","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.nefro.2015.05.022_bib0330","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ndt\/gfn488","article-title":"Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis","volume":"24","author":"Evenepoel","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0335","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/ndt\/gfq053","article-title":"Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study","volume":"25","author":"Brandenburg","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0340","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI109551","article-title":"Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: Evidence that alpha 2 HS glycoprptein is a negative acute-phase reactant","volume":"64","author":"Lebreton","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefro.2015.05.022_bib0345","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.nefro.2015.05.022_bib0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2215\/CJN.02810707","article-title":"Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients","volume":"3","author":"Caglar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0355","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1755-6686.2013.12009.x","article-title":"Comparison of sevelamer and calcium carbonate on endothelial function and inflammation in patients on peritoneal dialysis","volume":"39","author":"Chennasamudram","year":"2013","journal-title":"J Ren Care"},{"key":"10.1016\/j.nefro.2015.05.022_bib0360","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.2215\/CJN.01650211","article-title":"Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients","volume":"6","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0365","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2215\/CJN.02420409","article-title":"Mineral metabolism and inflammation in chronic kidney disease patients","volume":"4","author":"Navarro-Gonz\u00e1lez","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0370","first-page":"1037","volume":"29","author":"Levin","year":"2014","journal-title":"CanPREDDICT Investigators Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0375","first-page":"175","article-title":"Oxidative stress, inflammation and cardiovascular disease in chronic renal failure","volume":"21","author":"Cottone","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0380","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000321438","article-title":"A gut feeling on endotoxemia: causes and consequences in chronic kidney disease","volume":"118","author":"Hauser","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nefro.2015.05.022_bib0385","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0390","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ndt\/gfl558","article-title":"A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study","volume":"22","author":"Portol\u00e9s","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0395","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1093\/ndt\/gfn346","article-title":"Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS","volume":"23","author":"Akizawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1542-4758.2009.00376.x","article-title":"Predictors of anemia in patients on hemodialysis","volume":"13","author":"Aaseb\u00f8","year":"2009","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1440-1797.2011.01545.x","article-title":"Potential influence of sevelamer hydrochloride on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients","volume":"17","author":"Ikee","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.nefro.2015.05.022_bib0410","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ki.2013.110","article-title":"Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure","volume":"84","author":"Maizel","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0415","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0420","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0425","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2710.2007.00871.x","article-title":"Survival in end stage renal disease: calcium carbonate vs. sevelamer","volume":"32","author":"Borzecki","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.nefro.2015.05.022_bib0430","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2015.05.022_bib0435","first-page":"487","article-title":"INDEPENDENT Study Investigators","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0440","first-page":"771","article-title":"INDEPENDENT Study Investigators","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2015.05.022_bib0445","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0450","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.05.022_bib0455","first-page":"952","volume":"51","author":"Qunibi","year":"2008"},{"key":"10.1016\/j.nefro.2015.05.022_bib0460","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.108.797407","article-title":"Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification","volume":"119","author":"Maizel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2015.05.022_bib0465","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2012070719","article-title":"Cardiovascular effects of sevelamer in stage 3 CKD","volume":"24","author":"Chue","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0470","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0475","first-page":"245","article-title":"Treat to Goal Working Group","volume":"62","author":"Chertow","year":"2002","journal-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0480","doi-asserted-by":"crossref","first-page":"E212","DOI":"10.1002\/ccd.25387","article-title":"Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications","volume":"83","author":"Rocha-Singh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.nefro.2015.05.022_bib0485","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s10157-012-0640-4","article-title":"Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study","volume":"16","author":"Iimori","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.nefro.2015.05.022_bib0490","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk ofmortality","volume":"84","author":"Cannata-And\u00eda","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.05.022_bib0495","first-page":"432","article-title":"Experience with sevelamer in peritoneal dialysis","volume":"23","author":"Ortiz","year":"2003","journal-title":"Nefrologia"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T16:46:49Z","timestamp":1599324409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699515000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0211699515000363"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2015.05.022","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}